Quick Links
Past Events

Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.0 Contact Hour.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Foundation Medicine, Inc.

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

Precision Medicine for Community Oncologists: The Role of Tumor Testing Technologies in Cancer Care

Oncology Best Practice™: Precision Medicine for Community Oncologists: The Role of Tumor Testing Technologies in Cancer Care

In order to request this CME/CE activity for your center, please contact Samantha Zelasko at or call (609) 325-4668

Oncology Best Practice™:
Precision Medicine for Community Oncologists: The Role of Tumor Testing Technologies in Cancer Care
August 2017 - December 2017


This activity will bring key clinical experts in the medical management of cancer directly into 8 institutions with an identified educational need for an in-depth discussion with healthcare teams on regarding the optimization of diagnosis and treatment selection using different tumor testing technologies. The theme of this program will be a practical case-based approach that incorporates recent practice-changing trial data and places these findings in the context of real-world clinical situations that allows for clinical decision-making in multidisciplinary settings. Importantly, a small group setting held in the collegial atmosphere of grand rounds/tumor boards allows participants open, fluid interaction with key opinion leaders to get their most pressing patient issues addressed. Indeed, the patient will remain the focus of this activity via practical assessments of how specific patient characteristics impact thought processes in the clinic, and how quality measures that used for reimbursement can be addressed via evidence-based guidelines. All these important issues require careful assessment to inform treatment decisions and optimize care.

Target Audience

This educational activity is primarily directed toward medical oncologists who treat patients with cancer. It will be developed to meet the needs of the “everyday oncologist” in community practice. Additionally, fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the treatment of cancer are also invited to attend.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Analyze strategies for tumor testing in patients with cancer, including next-generation sequencing, liquid biopsies, comprehensive genomic profiling, hotspot analysis, and tissue biopsies
  • Implement best practices to individualize treatment of patients with cancer based on assessment of tumor profile and patient characteristics
  • Explain the role of multidisciplinary teams in facilitation and implementation of novel tumor testing technologies in clinical practice settings
  • Integrate office-based systems and guideline use to overcome barriers to personalized medicine and increase cancer screening in the community setting


William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology
Interim chief, Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center of Feinberg School of Medicine
Northwestern University
Chicago, IL

Become a Member

Forgot Password?
Calendar of Events
Filter By